Nexus AG (LON: 0FGL)
London
· Delayed Price · Currency is GBP · Price in EUR
68.80
-0.10 (-0.15%)
Jan 31, 2025, 2:59 PM BST
Nexus AG Revenue
Nexus AG had revenue of 64.23M EUR in the quarter ending September 30, 2024, with 6.63% growth. This brings the company's revenue in the last twelve months to 265.36M, up 13.94% year-over-year. In the year 2023, Nexus AG had annual revenue of 245.24M with 15.95% growth.
Revenue (ttm)
265.36M EUR
Revenue Growth
+13.94%
P/S Ratio
n/a
Revenue / Employee
137.49K EUR
Employees
1,930
Market Cap
988.91M GBP
Revenue Chart
* This company reports financials in EUR.
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 245.24M | 33.73M | 15.95% |
Dec 31, 2022 | 211.51M | 20.80M | 10.91% |
Dec 31, 2021 | 190.71M | 24.75M | 14.91% |
Dec 31, 2020 | 165.96M | 14.46M | 9.54% |
Dec 31, 2019 | 151.50M | 10.90M | 7.75% |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Dec 31, 2014 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
AstraZeneca | 38.20B |
GSK plc | 31.31B |
Haleon | 11.24B |
Smith & Nephew | 4.46B |
Hikma Pharmaceuticals | 2.39B |
ConvaTec Group | 1.74B |
HUTCHMED (China) | 483.31M |
Oxford Nanopore Technologies | 167.75M |